April 15, 2016 / 12:52 PM / a year ago

BRIEF-Intellipharmaceutics reports Q1 loss per share $0.09

April 15 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics announces first quarter 2016 results

* Q1 loss per share $0.09

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

* Plan to file new drug application for rexista oxycodone xr within three months on basis that no phase iii studies required

* Progress on rexista oxycodone xr continues, nda user fee waiver request filed Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below